Home > National Drug Code (NDC) > Anew Clinical

Anew Clinical - 10096-0304-5 - (Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone)

Alphabetical Index


Drug Information of Anew Clinical

Product NDC: 10096-0304
Proprietary Name: Anew Clinical
Non Proprietary Name: Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone
Active Ingredient(s): 28; 95; 75; 25.6; 47.5    mg/g; mg/g; mg/g; mg/g; mg/g & nbsp;   Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone
Administration Route(s): TOPICAL
Dosage Form(s): LOTION
Coding System: National Drug Codes(NDC)

Labeler Information of Anew Clinical

Product NDC: 10096-0304
Labeler Name: Avon Products, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20130522

Package Information of Anew Clinical

Package NDC: 10096-0304-5
Package Description: 1.1 g in 1 PACKET (10096-0304-5)

NDC Information of Anew Clinical

NDC Code 10096-0304-5
Proprietary Name Anew Clinical
Package Description 1.1 g in 1 PACKET (10096-0304-5)
Product NDC 10096-0304
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Avobenzone, Homosalate, Octinoxate, Octocrylene, Oxybenzone
Dosage Form Name LOTION
Route Name TOPICAL
Start Marketing Date 20130522
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Avon Products, Inc.
Substance Name AVOBENZONE; HOMOSALATE; OCTINOXATE; OCTOCRYLENE; OXYBENZONE
Strength Number 28; 95; 75; 25.6; 47.5
Strength Unit mg/g; mg/g; mg/g; mg/g; mg/g
Pharmaceutical Classes

Complete Information of Anew Clinical


General Information